ICU Medical (NASDAQ:ICUI) Shares Cross Above 200 Day Moving Average – Should You Sell?

ICU Medical, Inc. (NASDAQ:ICUI)’s stock price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $157.00 and traded as high as $162.01. ICU Medical shares last traded at $160.99, with a volume of 133,187 shares changing hands.

Wall Street Analysts Forecast Growth

ICUI has been the topic of several recent analyst reports. Jefferies Financial Group raised ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 price target on the stock in a research report on Wednesday, December 11th. StockNews.com raised shares of ICU Medical from a “hold” rating to a “buy” rating in a research report on Wednesday, November 20th. Needham & Company LLC reissued a “hold” rating on shares of ICU Medical in a research report on Wednesday, November 13th. Finally, KeyCorp upped their price target on ICU Medical from $198.00 to $209.00 and gave the company an “overweight” rating in a report on Wednesday, November 13th. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat, ICU Medical has an average rating of “Moderate Buy” and an average price target of $199.67.

ICU Medical Stock Down 4.1 %

The company has a market capitalization of $3.78 billion, a P/E ratio of -33.77 and a beta of 0.63. The business’s fifty day moving average price is $163.34 and its 200 day moving average price is $157.00. The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75.

Insider Buying and Selling at ICU Medical

In other news, CEO Vivek Jain sold 12,000 shares of the company’s stock in a transaction dated Friday, November 1st. The shares were sold at an average price of $171.84, for a total value of $2,062,080.00. Following the sale, the chief executive officer now owns 104,593 shares of the company’s stock, valued at approximately $17,973,261.12. This represents a 10.29 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director David C. Greenberg sold 972 shares of ICU Medical stock in a transaction dated Wednesday, November 27th. The shares were sold at an average price of $158.11, for a total transaction of $153,682.92. Following the transaction, the director now directly owns 5,037 shares of the company’s stock, valued at $796,400.07. This represents a 16.18 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 29,737 shares of company stock valued at $4,941,832. 6.70% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On ICU Medical

Hedge funds and other institutional investors have recently bought and sold shares of the business. Rhumbline Advisers grew its holdings in shares of ICU Medical by 23.0% during the second quarter. Rhumbline Advisers now owns 66,916 shares of the medical instruments supplier’s stock worth $7,946,000 after purchasing an additional 12,519 shares during the last quarter. Victory Capital Management Inc. lifted its position in ICU Medical by 2,966.3% during the 2nd quarter. Victory Capital Management Inc. now owns 141,848 shares of the medical instruments supplier’s stock worth $16,844,000 after buying an additional 137,222 shares in the last quarter. Arizona State Retirement System lifted its position in ICU Medical by 7.9% during the 2nd quarter. Arizona State Retirement System now owns 6,082 shares of the medical instruments supplier’s stock worth $722,000 after buying an additional 443 shares in the last quarter. Savant Capital LLC bought a new stake in ICU Medical during the 2nd quarter worth about $431,000. Finally, Choreo LLC acquired a new stake in ICU Medical in the 2nd quarter valued at about $313,000. 96.10% of the stock is owned by institutional investors and hedge funds.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.